Novartis Habitrol Will Be Relaunched for Combo Use By Grey
Executive Summary
Novartis is negotiating with FDA on Habitrol labeling revisions to include combination treatment with an undisclosed prescription product. Glaxo Wellcome's Zyban (bupropion), also indicated for smoking cessation, is a likely candidate.